Strand by Strand: Unraveling the Basics of Pharmacogenomics

Strand by Strand: Unraveling the Basics of Pharmacogenomics

This foundational pharmacogenomics course explores how genetic makeup profoundly impacts drug efficacy and safety. Beyond conventional approaches, pharmacogenomics offers a roadmap to tailor treatments with precision. By unraveling genetic nuances in patients, healthcare professionals gain the expertise to navigate personalized therapy plans while minimizing trial-and-error approaches that often prolong negative outcomes. This informative course acts as a catalyst for healthcare professionals seeking to elevate practice standards by integrating cutting-edge pharmacogenomic testing and analysis into their practice. These principles will provide the essential tools to make informed, evidence-based decisions, ultimately optimizing patient outcomes and revolutionizing the delivery of health care.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Define pharmacogenomics and phenoconversion and their role in tailoring drug treatments to individuals
2. Review ethical, legal, and social issues (ELSI) and regulatory concerns surrounding PGx testing
3. Identify key drug-gene interactions and their impact on an individual’s reaction to a specific medication
4. Discuss how genetic information can inform drug selection and dosage adjustments for personalized treatment
5. Interpret pharmacogenomic guidelines to inform therapeutic recommendations for clinical scenarios

Sarah Mills, PharmD, BCPS
Clinical Pharmacy Practitioner, Pharmacogenomics
Durham Veterans Affairs Health Care System

Sarah Mills has no relevant financial relationships with ineligible companies to disclose.  

Financial support was provided for this course through an unrestricted educational grant from RxGenomix, a comprehensive pharmacogenomics (PGx) solutions company dedicated to empowering healthcare providers to optimize and scale the application of PGx.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: January 1, 2024
Planned Expiration Date: January 1, 2027

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

Universal Activity Number (UAN): 0107-0000-24-026-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


1h 0m

Topic Designator




ACPE Topic

01 Drug Therapy





Release Date






ACPE Number


This course is in our subscription.